nach oben

Erschienen in:

01.10.2007 | News item

Gadolinium-containing contrast agents are associated with an increased risk of nephrogenic systemic fibrosis

Erschienen in: Reactions Weekly | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Excerpt

Gadolinium-containing contrast agents are associated with an increased risk of nephrogenic systemic fibrosis (NSF). To date, NSF has only been reported in patients with kidney disease. Up to June 2007, a total of 5 cases of NSF with a suspected association with gadolinium-containing contrast agent were reported in Canada. Tanja Kalajdzic from Health Canada concludes that “voluntary reporting to Health Canada remains an important postmarketing surveillance tool to further elucidate this disorder”. …

Kalajdzic T.Gadolinium-containing contrast agents and nephrogenic systemic fibrosis: update. Canadian Adverse Reaction Newsletter 17: 1-2, No. 4, Oct 2007

Titel: Gadolinium-containing contrast agents are associated with an increased risk of nephrogenic systemic fibrosis
Publikationsdatum: 01.10.2007
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2007
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-200711750-00008

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Gadolinium-containing contrast agents are associated with an increased risk of nephrogenic systemic fibrosis

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Chlorzoxazone

BMS advises of serious reactions with perflutren

Lisinopril

Rituximab

Thiamazole

Valproic acid